Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Journal of Parkinson'S Disease
|
May 3, 2014
Serum uric acid concentration is linked to wearing-off fluctuation in Japanese Parkinson's disease patients
Jiro Fukae, Kei-Ichi Ishikawa, Taku Hatano, et al.
Parkinsonism & Related Disorders
|
May 4, 2013
Motor and non-motor symptoms of 1453 patients with Parkinson's disease: prevalence and risks
Asako Yoritaka, Yasushi Shimo, Masashi Takanashi, et al.
Clinical Neurology and Neurosurgery
|
April 23, 2017
Serum uric acid level is linked to the disease progression rate in male patients with multiple system atrophy
Jiro Fukae, Shinsuke Fujioka, Shosaburo Yanamoto, et al.
The Neurologist
|
February 28, 2012
Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis
Kotaro Ogaki, Takashi Hirayama, Karina Chijiiwa, et al.
Internal Medicine (Tokyo, Japan)
|
August 4, 2017
The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study
Shinji Ouma, Jiro Fukae, Shinsuke Fujioka, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 29, 2014
A novel DCTN1 mutation with late-onset parkinsonism and frontotemporal atrophy
Eiichi Araki, Yoshio Tsuboi, Justus Daechsel, et al.
Clinical Neurology and Neurosurgery
|
May 19, 2015
Utility of the Japanese version of the 9-item Wearing-off Questionnaire
Jiro Fukae, Masa-aki Higuchi, Shosaburo Yanamoto, et al.
Human Molecular Genetics
|
February 28, 2006
Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease
Ikuko Mizuta, Wataru Satake, Yuko Nakabayashi, et al.
BMC Neurology
|
May 14, 2016
A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics
Asako Yoritaka, Takashi Abe, Chigumi Ohtsuka, et al.
BMJ Open
|
February 12, 2022
Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD)
Taku Hatano, Genko Oyama, Yasushi Shimo, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Journal of Parkinson'S Disease
|
May 3, 2014
Serum uric acid concentration is linked to wearing-off fluctuation in Japanese Parkinson's disease patients
Jiro Fukae, Kei-Ichi Ishikawa, Taku Hatano, et al.
Parkinsonism & Related Disorders
|
May 4, 2013
Motor and non-motor symptoms of 1453 patients with Parkinson's disease: prevalence and risks
Asako Yoritaka, Yasushi Shimo, Masashi Takanashi, et al.
Clinical Neurology and Neurosurgery
|
April 23, 2017
Serum uric acid level is linked to the disease progression rate in male patients with multiple system atrophy
Jiro Fukae, Shinsuke Fujioka, Shosaburo Yanamoto, et al.
The Neurologist
|
February 28, 2012
Anti-aquaporin-4 antibody-positive definite neuromyelitis optica in a patient with thymectomy for myasthenia gravis
Kotaro Ogaki, Takashi Hirayama, Karina Chijiiwa, et al.
Internal Medicine (Tokyo, Japan)
|
August 4, 2017
The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study
Shinji Ouma, Jiro Fukae, Shinsuke Fujioka, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 29, 2014
A novel DCTN1 mutation with late-onset parkinsonism and frontotemporal atrophy
Eiichi Araki, Yoshio Tsuboi, Justus Daechsel, et al.
Clinical Neurology and Neurosurgery
|
May 19, 2015
Utility of the Japanese version of the 9-item Wearing-off Questionnaire
Jiro Fukae, Masa-aki Higuchi, Shosaburo Yanamoto, et al.
Human Molecular Genetics
|
February 28, 2006
Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease
Ikuko Mizuta, Wataru Satake, Yuko Nakabayashi, et al.
BMC Neurology
|
May 14, 2016
A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics
Asako Yoritaka, Takashi Abe, Chigumi Ohtsuka, et al.
BMJ Open
|
February 12, 2022
Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson's disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group stud (CONST-PD)
Taku Hatano, Genko Oyama, Yasushi Shimo, et al.
Page
of 7